DRAGONASE LLC

From the company

Dragonase is solving a critical bottleneck in hematopoietic stem cell (HSC) expansion, which is essential for emerging cell therapies but currently slow, expensive, and often insufficient for clinical needs. Their solution combines a robotic lab and an AI scientist to produce a closed-loop, self-driving lab, addressing the need for expanded HSC production and serving as a versatile platform for researching rejuvenation and developing cell therapies.